Start Submission Become a Reviewer

Reading: Five year follow-up of patients with high cardiovascular risk in the Turkish population. Wha...

Download

A- A+
Alt. Display

Research

Five year follow-up of patients with high cardiovascular risk in the Turkish population. What are the predictors of highest cardiovascular risk?

Authors:

Hakan Kültürsay ,

Ege University, Medical School, Cardiology Department, Bornova, İzmir, TR
X close

Lale Tokgözoğlu,

Hacettepe University, Medical School, Cardiology Department, Ankara, TR
X close

Taner Damcı,

İstanbul University, Medical School, Internal Medicine Department, İstanbul, TR
X close

Aytekin Oğuz,

Göztepe SSK Educational Hospital, Internal Medicine Clinic, İstanbul, TR
X close

Seçkin Pehlivanoğlu,

Başkent University Hospital, Cardiology Department, İstanbul, TR
X close

Mustafa Şenocak,

Istanbul University, Department of Statistics, İstanbul, TR
X close

Mehmet Yusuf

Bogazici University, Biomedical Engineering Institute, Altis Clinical Research Organization, İstanbul, TR
X close

Abstract

Background: Despite the overwhelming evidence from clinical trials showing that preventive measures recommended by recent guidelines significantly reduce mortality, the implementation rate in patients with high cardiovascular risk is still far from optimal.

Methods: A total of 5600 patients with a high cardiovascular risk were invited to participate however 3331 (59%) agreed to a five year follow-up in a multicenter, observational study. Primary end-points included death, myocardial infarction, stroke and optimal medication use over 5 years.

Results: Primary end-points including cardiovascular mortality were higher in patients with vascular disease (25.3% vs 15.1%, p < 0.001, and 13.5 vs 6.2%, p < 0.001, respectively) and it was doubled in 5 years. Presence of end organ damage further increased the incidence of primary end-point and cardiovascular mortality (30.6% vs 16.2%, p < 0.001 and 18.1% vs 6.8%, p < 0.001, respectively). The optimal preventive treatment (statin, renin-angiotensin system blocker, beta-blocker and antiplatelet) rate was low and did not change significantly in 5 years, although the consistent use of angiotensin-converting enzyme inhibitor seemed to be a protective predictor of cardiovascular mortality.

Conclusion: In this high risk Turkish population, mortality and morbidity in the medium to long term were high and the implementation rate of optimal preventive treatment unacceptably low. The highest risk subgroup was identified to be those with previous vascular disease/event and end organ damage requiring aggressive medical treatment.

How to Cite: Kültürsay H, Tokgözoğlu L, Damcı T, Oğuz A, Pehlivanoğlu S, Şenocak M, et al.. Five year follow-up of patients with high cardiovascular risk in the Turkish population. What are the predictors of highest cardiovascular risk?. Global Heart. 2009;4(2):131–8. DOI: http://doi.org/10.1016/j.cvdpc.2008.11.001
Published on 01 Jun 2009.

Downloads

  • PDF (EN)

    comments powered by Disqus